EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Intensive blood pressure control and risks of cognitive outcomes in patients with new-onset orthostatic hypotension

Siyu Wang, Jingya Wang, Yueyue Wang, Xiaoli Xu, Haoqing Gu, Wanting Xie, Le Cai, Junheng Zhang, Tiange Wang iD, Zhiyun Zhao iD, Mian Li iD, Jie Zheng iD und 4 weitere

Age and Ageing · 03.01.2026 · 55 (1)

DOI: 10.1093/ageing/afag005 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Age and Ageing, online erschienen am 29.01.2026. Verfasst von Siyu Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong Universit…. Hauptthemen laut MEDLINE: Hypotension, Orthostatic, Cognitive Dysfunction, Blood Pressure, Antihypertensive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Orthostatic hypotension (OH) increases the risk of dementia. Although intensive blood pressure (BP) lowering may have cognitive benefits regardless of baseline OH status, its effects in participants who develop OH during intervention remain unknown.

Methods

Participants of the Systolic Blood Pressure Intervention Trial (SPRINT) were randomised to either intensive treatment (systolic BP target <120 mmHg) or standard treatment (systolic BP target <140 mmHg). This post hoc analysis defined new-onset OH as a systolic BP reduction ≥20 mmHg and/or a diastolic BP reduction ≥10 mmHg from a seated to a standing position at any follow-up visit during intervention. The primary outcome was probable dementia. Other outcomes included mild cognitive impairment (MCI), and a composite of probable dementia or MCI.

Results

Amongst 7911 participants without OH at baseline (representing 84.5% of randomised participants in SPRINT; mean age, 67.7 years; 34.7% women), 1264 (16.0%) developed new-onset OH during intervention. Intensive treatment was associated with a lower risk of probable dementia (HR, 0.76; 95% CI, 0.58 to 0.98) amongst participants without new-onset OH, but with a higher risk (HR, 2.39; 95% CI, 1.33 to 4.32) amongst participants with new-onset OH. No significant association was observed between intensive treatment and MCI, or the composite outcome in participants with new-onset OH.

Conclusions

The occurrence of OH requires close monitoring, with caution for potential cognitive adverse effects during ongoing intensive BP-lowering treatment. Validation of current findings in studies with justified methodological designs is warranted. Registration URL: ClinicalTrials.gov; Unique Identifier: NCT01206062.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypotension, OrthostaticCognitive DysfunctionBlood PressureAntihypertensive AgentsDementiaCognitionHumansFemaleAgedMaleMiddle AgedRisk FactorsTreatment OutcomeRisk Assessment

Stichwörter der Autor:innen

blood pressureintensive blood pressure controlmild cognitive impairmentolder peopleorthostatic hypotensionprobable dementia

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • National Clinical Research Center for Metabolic Diseases (Shanghai), Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, St…
  • Lifecycle Health Management Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • College of Public Health, Shanghai Jiao Tong University, Shanghai 200025, China.

ORCID-Profile: Tiange Wang, Zhiyun Zhao, Mian Li, Jie Zheng, Min Xu, Yufang Bi, Yu Xu

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Shanghai Municipal Government
  • Shanghai Clinical Research Center for Metabolic Diseases
  • Innovative Research Team of High-Level Local Universities in Shanghai
  • Undergraduate Training Program on Innovation (Key Fields Program)
  • Shanghai Jiao Tong University School of Medicine

Zitieren

APA

Wang, S., Wang, J., Wang, Y., Xu, X., Gu, H., Xie, W., Cai, L., Zhang, J., Wang, T., Zhao, Z., Li, M., Zheng, J., Xu, M., Lu, J., Bi, Y., & Xu, Y. (2026). Intensive blood pressure control and risks of cognitive outcomes in patients with new-onset orthostatic hypotension. Age and Ageing, 55(1). https://doi.org/10.1093/ageing/afag005

Vancouver

Wang S, Wang J, Wang Y, Xu X, Gu H, Xie W, et al. Intensive blood pressure control and risks of cognitive outcomes in patients with new-onset orthostatic hypotension. Age and Ageing. 2026;55(1). doi:10.1093/ageing/afag005

BibTeX
@article{Wang2026,
  author = {Wang, Siyu and Wang, Jingya and Wang, Yueyue and Xu, Xiaoli and Gu, Haoqing and Xie, Wanting and Cai, Le and Zhang, Junheng and Wang, Tiange and Zhao, Zhiyun and Li, Mian and Zheng, Jie and Xu, Min and Lu, Jieli and Bi, Yufang and Xu, Yu},
  title = {Intensive blood pressure control and risks of cognitive outcomes in patients with new-onset orthostatic hypotension},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {1},
  doi = {10.1093/ageing/afag005}
}
Kostenlos starten →